In vitro and in vivo study of fosfomycin in methicillin-resistant Staphylococcus aureus septicaemia

J Hyg (Lond). 1986 Jun;96(3):419-23. doi: 10.1017/s0022172400066183.

Abstract

Five hundred strains of methicillin-resistant Staphylococcus aureus were tested against various anti-staphylococcal agents. Vancomycin, fusidic acid and fosfomycin were found to be the most effective. Only 1 strain out of 500 was resistant to fosfomycin. Three patients with methicillin-resistant Staphylococcus aureus septicaemia were successfully treated by fosfomycin. We conclude that fosfomycin could be the drug of choice for methicillin-resistant Staphylococcus aureus infection.

MeSH terms

  • Adult
  • Female
  • Fosfomycin / pharmacology*
  • Fosfomycin / therapeutic use
  • Humans
  • Male
  • Methicillin / pharmacology*
  • Middle Aged
  • Penicillin Resistance
  • Sepsis / drug therapy*
  • Staphylococcal Infections / drug therapy*
  • Staphylococcus aureus / drug effects

Substances

  • Fosfomycin
  • Methicillin